• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct6
CSL Limited signs public reimbursement LOI for HEMGENIX with Pan-Canadian Pharmaceutical Alliance
12:26
Aug19
CSL Limited released FY2025 9 Months Earnings on August 18 (EST), with actual revenue of USD 12.02 B and EPS of USD 2.5751
03:00
CSL Limited released FY2025 Q4 earnings on August 18 (EST) with actual revenue of USD 3.538 B and EPS of USD 0.5101
03:00
CSL Limited released FY2025 earnings on August 18 During-Market (EST), actual revenue USD 15.56 B (forecast USD 15.72 B), actual EPS USD 3.1
03:00
CSL Limited released FY2025 Q3 earnings on August 18 (EST), actual revenue USD 3.538 B, actual EPS USD 0.5101
03:00
Aug11
CSL Limited to Release FY2025 Earnings on August 18 During-Market EST, Forecast Revenue USD 15.72 B
00:06

Schedules & Filings

Schedules
Filings
Feb9
Earning Release(EST)

FY2026 Semi-Annual Earning Release

Oct10
Distribution Plan(EST)

Cash dividend 0.81 USD

Sep10
Distribution Plan(EST)

Cash dividend 0.81 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More